🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, open-label, phase II clinical study conducted in Chi...
Status
Completed
Location
Hunan Cancer Hospital
Start Date
2021-04-01
Trial ID
NCT04868708
Treatments Being Tested
Recent studies suggest that patients with metastatic melanoma whose gut mic...
Status
Completed
Location
Ambroise Paré
Start Date
2022-01-20
Trial ID
NCT04988841
Treatments Being Tested
This phase I trial studies the side effects and best dose of ipilimumab and...
Status
Completed
Location
Yale University
Start Date
2012-12-14
Trial ID
NCT01757639
Treatments Being Tested
The main purpose of this trial is to investigate the effects of a new class...
Status
Completed
Location
Northwestern University
Start Date
2016-11-01
Trial ID
NCT02794883
Treatments Being Tested
This randomized phase II trial studies how well nivolumab works with or wit...
Status
Completed
Location
Sutter Auburn Faith Hospital
Start Date
2015-08-10
Trial ID
NCT02498600
Treatments Being Tested
To assess the safety and tolerability, characterize the dose-limiting toxic...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2012-12
Trial ID
NCT01750580
Treatments Being Tested
JTX-2011-201 is a Phase 2, open label clinical study of vopratelimab (JTX-2...
Status
Completed
Location
Beverly Hills Cancer Center
Start Date
2019-06-06
Trial ID
NCT03989362
Treatments Being Tested
This is an open-label randomized phase II study. Patients are randomized so...
Status
Withdrawn
Location
University of California
Start Date
2015-06
Trial ID
NCT01530984
Treatments Being Tested
This phase II trial studies how well high-dose aldesleukin and ipilimumab w...
Status
Terminated
Location
Loyola University Medical Center
Start Date
2014-11-26
Trial ID
NCT02203604
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of olaparib wh...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2017-06-29
Trial ID
NCT02953457
Treatments Being Tested